May 14, 2019
BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 7, 2019
BioLineRx to Report First Quarter 2019 Results on May 14, 2019
May 7, 2019
BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors
March 28, 2019
BioLineRx Reports Year End 2018 Financial Results and Provides Corporate Update